Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1281 of 5804
-
Knee gel injection aims to ease arthritis pain without surgery
Symptom relief CompletedOsteoarthritis (OA) is a chronic degenerative joint disease characterized macroscopically by progressive damage of articular cartilage, joint space narrowing, subchondral bone remodelling, joint marginal osteophyte formation and synovitis. It is also characterized by a decrease o…
Phase: NA • Sponsor: Symatese • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could a baking soda rinse tame radiation mouth sores?
Disease control OngoingTo evaluate whether the use of 2.5% sodium bicarbonate mouthwash throughout the entire course of radiotherapy for nasopharyngeal carcinoma reduces the severity of radiation-induced oral mucositis and improves patient adherence to treatment.
Phase: PHASE2, PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New injection could save ovaries in endometriosis cyst surgery
Disease control Recruiting nowA randomised controlled trial assessing ovarian reserve after laparoscopic ethanol sclerotherapy of ovarian endometrioma compared to standard treatment of surgical excision of endometrioma. Secondary outcomes will include endometrioma recurrence, symptomatology and inflammatory …
Phase: NA • Sponsor: Chelsea and Westminster NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can cilastatin shield kidneys during ovarian cancer surgery?
Disease control Recruiting nowTo compare cilastatin vs thiosulfatein renal protection in patients undergoing debulking surgery with intraoperative hyperthermic intraperitoneal chemotherapy with cisplatin
Phase: PHASE2 • Sponsor: Hospital General Universitario Gregorio Marañon • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New pill shows promise for Long-Term control of binge eating
Disease control ENROLLING_BY_INVITATIONThis is a Phase 3, multi-center, open-label study to evaluate the long-term safety and efficacy of solriamfetol in the treatment of binge eating disorder (BED) in adults.
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New hope for advanced cancer patients as experimental drug enters human trials
Disease control Recruiting nowThis study is testing a new medicine, SNV4818, for people with advanced cancers. The researchers want to find out if SNV4818 is safe, well-tolerated, and effective in treating solid tumors. They are investigating different doses in order to find the safest and most effective one.
Phase: PHASE1, PHASE2 • Sponsor: Pikavation Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New hope for lymphoma patients: drug duo aims to shrink tumors
Disease control Recruiting nowThe purpose of this clinical trial is to learn if the drugs Pirtobrutinib and Rituximab are effective for the treatment of newly diagnosed marginal zone lymphoma.
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Can more coaching beat childhood obesity? 900 kids put to the test
Disease control Recruiting nowThe research team is recruiting 900 children between the ages 5-17 with obesity from Tennessee and Louisiana. The team is assigning children and their caregivers by chance to one of five groups. In the first group, 300 children and their caregivers receive 26 hours of IBT. In the…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 26, 2026 15:21 UTC
-
Memory shield: turmeric and brain games may ward off cognitive decline in At-Risk seniors
Prevention OngoingIntroduction: The Insulin resistance itself has been recognized as an independent risk factor for dementia development. Insulin plays an important role in the regulation of muscle function and the processes of learning and memory. Insulin resistance is associated with increased i…
Phase: PHASE2, PHASE3 • Sponsor: Instituto Mexicano del Seguro Social • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Can ribociclib keep breast cancer from coming back? new study tracks Real-World results
Disease control Recruiting nowThis non-interventional observational study evaluates the real-world effectiveness and safety profile of ribociclib in combination with an aromatase inhibitor for adjuvant treatment in patients with HR+/HER2- early breast cancer at high risk of recurrence, as well as patient comp…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a biologic drug spare patients from repeat throat surgeries?
Disease control CompletedThe purpose of this phase 2 study is to examine if inhibiting IL-17A activation using the biologic drug Taltz, in idiopathic subglottic stenosis patients will decrease scar fibroblast proliferation therefore reducing or eliminating the need for invasive or repeat surgeries.
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
AI could help doctors detect celiac disease during endoscopy
Diagnosis Recruiting nowCoeliac disease (CD) is an immune-mediated enteropathy leading to small intestinal mucosal atrophy. Diagnosis relies on serology and duodenal biopsies, but it can be complicated by patchy lesions and differential diagnosis with Non-Celiac Enteropathies (NCEs). This multicenter ob…
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
New shot could tame lupus skin flares
Disease control OngoingThe primary purpose of this study is to evaluate the efficacy, safety, and tolerability of IMVT-1402 in participants with Cutaneous Lupus Erythematosus. The study will consist of 3 periods: Period 1: eligible participants will be randomized 1:1 to IMVT-1402 Dose 1 or placebo SC…
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
AI could predict which cancer patients will relapse after surgery
Knowledge-focused Recruiting nowColorectal cancer is the third most common cancer worldwide and the fourth most common cause of cancer-related death. Survival is primarily determined by stage of disease and the presence of metastases. The combination of chemotherapy and liver resection remains the treatment opt…
Sponsor: Francesco De Cobelli • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
AI coach helps oral cancer survivors move better
Symptom relief Recruiting nowThis study examines the effects of AI-based physiotherapy on oral function, shoulder function, whole-body physical function, and quality of life in oral cancer patients. One hundred patients will be recruited before surgery, chemotherapy, or radiotherapy and randomly assigned to …
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
One-Week radiation shows promise for breast cancer patients
Disease control Recruiting nowThis study evaluates the rates of radiation-specific toxicity, quality of life, and oncologic outcomes for early-stage breast cancer and ductal carcinoma in situ treated with 5-fraction whole breast irradiation (WBI) with a simultaneous integrated tumor bed boost (SIB). SIB refer…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Tango therapy may ease chemo nerve pain in breast cancer survivors
Symptom relief Recruiting nowUp to 80% of breast cancer survivors experience chemotherapy-induced neuropathy that impairs quality of life and increases fall risk long into survivorship, yet treatment options for neuropathy remain limited. The successful treatment will target neurophysiologic mechanisms for r…
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Balloon procedure could stop minor strokes from getting worse
Disease control Recruiting nowIntracranial atherosclerotic stenosis (ICAS) is a common cause of stroke, especially in East and South Asia, and is significantly associated with stroke recurrence and early neurological deterioration (END) despite aggressive medical management. Minor stroke (National Institutes …
Phase: NA • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Immune cell shot aims to tame tough lupus cases
Disease control Recruiting nowThis is an investigator-initiated, open-label, single-arm study to determine safety and preliminary efficacy of NK010 or NK042 in combination with rituximab (RTX) for the treatment of patients with refractory systemic lupus erythematosus (SLE) or lupus nephritis (LN) in China.
Phase: PHASE1 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Malaria-Fighting drug given to entire villages shows promise
Disease control CompletedTheoretically, so long as there is a sink-source for malaria, transmission could be sustained at very low level (even at sub-microscopic oscillation) and reintroduce malaria either as sporadic cases or as resurgent outbreak. Uncertainty or shortage in financing has typically limi…
Phase: PHASE4 • Sponsor: Shoklo Malaria Research Unit • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC